William K. Heiden
2017
In 2017, William K. Heiden earned a total compensation of $4.3M as President and Chief Executive Officer at AMAG Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $553,350 |
|---|---|
| Option Awards | $729,274 |
| Salary | $702,973 |
| Stock Awards | $2,355,350 |
| Other | $8,100 |
| Total | $4,349,047 |
Heiden received $2.4M in stock awards, accounting for 54% of the total pay in 2017.
Heiden also received $553.4K in non-equity incentive plan, $729.3K in option awards, $703K in salary and $8.1K in other compensation.
Rankings
In 2017, William K. Heiden's compensation ranked 2,296th out of 14,666 executives tracked by ExecPay. In other words, Heiden earned more than 84.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,296 out of 14,666 | 84th |
Division Manufacturing | 801 out of 5,772 | 86th |
Major group Chemicals And Allied Products | 215 out of 2,075 | 90th |
Industry group Drugs | 164 out of 1,731 | 91st |
Industry Pharmaceutical Preparations | 129 out of 1,333 | 90th |
Source: SEC filing on April 25, 2018.
Heiden's colleagues
We found four more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2017.